Members Only Content

Subscribe to get full access

Free Preview

Seres Therapeutics has just begun selling its first FDA-approved drug, yet the stock has been selling off all month. What's the takeaway for investors?

related news & insights

  • March 10, 2025||7.5 min||||

    Using Options as a Long-Term Investing Strategy with Jeff Fischer

    When used responsibly, options can be a fantastic way to boost the overall returns of an investment portfolio. But options [...]

  • February 14, 2025||0 min||||

    Novo Nordisk Deep Dive: February 2025

    Novo Nordisk Recommendation Feb 2025

  • February 1, 2025||4.9 min||||

    X’s Favorite Small-Cap Growth Stocks

    We did something special this month. In addition to sharing our 7investing Community's favorite new ideas, we also asked an [...]